European Commission Approves Astellas’ XOSPATA™ for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay

2019-10-30T17:00:23+00:00October 30th, 2019|Categories: Press Releases|Tags: , , , , , , , , |

⟵  PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]